Abstract Patients who undergo implantation of a tissueengineered vascular graft (TEVG) for congenital cardiac anomalies are monitored with echocardiography, followed by magnetic resonance imaging or angiography when indicated. While these methods provide data regarding the lumen, minimal information regarding neotissue formation is obtained. Intravascular ultrasound (IVUS) has previously been used in a variety of conditions to evaluate the vessel wall. The purpose of this study was to evaluate the utility of IVUS for evaluation of TEVGs in our ovine model. Eight sheep underwent implantation of TEVGs either unseeded or seeded with bone marrow-derived mononuclear cells. Angiography, IVUS, and histology were directly compared. Endothelium, tunica media, and graft were identifiable on IVUS and histology at multiple time points. There was strong agreement between IVUS and angiography for evaluation of luminal diameter. IVUS offers a valuable tool to evaluate the changes within TEVGs, and clinical translation of this application is warranted.
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Introduction
Approximately 40,000 babies born in the US are affected by congenital cardiac anomalies every year [1] . Nearly 25% of these children will require surgical interventions that can Associate Editor Adrian Chester oversaw the review of this article Victoria K. Pepper and Elizabeth S. Clark are shared first authors.
* Christopher K. Breuer christopher.breuer@nationwidechildrens.org require synthetic patches or conduits [2, 3] . Our laboratory has pioneered a biodegradable tissue-engineered vascular graft (TEVG) for use in these conditions that is composed of polyglycolic acid (PGA) fibers that are knitted into a tube and coated with a 50:50 copolymer of polycaprolactone and polylactic acid (PCLA). In contrast to typical synthetic conduits, tissue-engineered scaffolds offer the potential for growth in this pediatric population, while also mitigating some of the complications related to traditional vascular prostheses such as infection and chronic inflammation. The TEVG was applied in a first-in-man clinical trial in 25 children undergoing an extracardiac Fontan procedure [4, 5] . Results from this trial identified that the grafts demonstrated growth, but there was a 30% incidence of stenosis and half of these patients required transcatheter interventions. Currently, these grafts are followed in a similar fashion to other vascular conduits used in the surgical reconstruction of congenital cardiac anomalies, which typically includes routine echocardiographic imaging. If required, more invasive measures, such as computed tomography (CT), magnetic resonance imaging (MRI), angiography, or intravascular ultrasound (IVUS), may be used to evaluate complications associated with the TEVG, such as the development of stenosis or aneurysmal dilation. While these imaging modalities have been used to characterize traditional synthetic grafts in both animals and humans, only echocardiogram, MRI, pressure measurements, and angiography have routinely been used within the patients receiving TEVGs. One limitation of echocardiogram and angiography is the inability to provide definitive analysis of the vessel wall and the need to identify the lumen based on either blood flow or administration of a contrast agent. However, angiography remains the clinical gold standard for determination of TEVG stenosis and the requirement for endovascular intervention.
IVUS has recently been utilized in a wide variety of intravascular conditions. It is most frequently described in the adult population with placement of stents for the treatment of aneurysms or atherosclerosis [6] [7] [8] [9] [10] . The advantages of this technique are a limitation of contrast use, a two-dimensional view of the vessel lumen, an ability to determine true from false lumens, and accurate assessment of stent apposition to the luminal wall [11] [12] [13] . Intravascular pathology, such as thrombus, can also be more specifically evaluated than with angiography, which may only show luminal occlusion or a partial filling defect [14] . In addition, IVUS can be used to evaluate pathology within the walls of vessels using radiofrequency backscatter analysis or virtual histology in processes such as coronary artery disease or peripheral vascular disease [13, [15] [16] [17] [18] . Unlike angiography, IVUS can be used to evaluate early plaque development and remodeling of this pathology, identifying the vulnerability of these plaques based on their imaging characteristics [19, 20] . Additionally, histology can correlate directly with IVUS, identifying necrotic, lipidic, fibrotic, and calcific areas within vessel walls [15] [16] [17] 21] .
The use of IVUS in pediatric conditions is less thoroughly described. However, it has been used to evaluate children with pulmonary hypertension, valvular disease, pulmonary artery stenosis, coarctation of the aorta, and Kawasaki disease. Specifically, findings of medial hypertrophy and intimal hyperplasia have been correlated with increased pulmonary hypertension [22] [23] [24] [25] . IVUS has also been used in a fashion similar to that in adults in examining the placement of intravascular stents [6, 26] . These conditions share a commonality in that they all lead to vessel wall changes, suggesting that the use of IVUS in patients receiving TEVGs would allow surveillance of growth, remodeling, and the development of pathologic lesions within the walls of the evolving neovessel, which would surpass the capabilities of traditional angiographic imaging. These changes in vessel morphology have been previously characterized histologically in both murine and ovine models, but association with IVUS could provide a potentially useful tool for monitoring TEVGs in the clinical setting. Therefore, the purpose of this study is to examine the correlation between histology and IVUS imaging and to evaluate the agreement in measures of vessel morphology between IVUS and angiography using an ovine model of TEVG implantation. 
Scaffold Fabrication
TEVG scaffolds (12-20 mm inner diameter, 1.0 mm wall thickness, 13 cm length) were provided by Gunze Ltd. (Tokyo, Japan). Scaffolds (Fig. 1a, b) were fabricated from seamless tubes of knitted poly-glycolic acid (PGA) fibers coated with a 50:50 copolymer solution of polycaprolactone and polylactic acid (PCLA) following GMP protocols as previously described [4] . The scaffolds used in this study are identical to those used in our current clinical trial (FDA IDE 14127).
Bone Marrow Harvest
Four of eight sheep underwent bone marrow harvest for graft seeding. On the day before (n = 2) or the morning of surgery (n = 2), marrow was harvested from juvenile sheep weighing between 22 and 28 kg. Sheep were anesthetized using ketamine (10 mg/kg) and diazepam (0.5 mg/kg) for induction and isoflurane (1-4%) for maintenance. Animals were placed in the lateral recumbent position, and the area overlying the iliac crest was shaved and prepped in the standard sterile fashion. A 2-mm incision was made over the bone and an aspiration needle was inserted. Heparinized syringes (100 U/ml) were used to aspirate 4.6 ± 0.9 ml/kg of bone marrow.
Scaffold Seeding
Following harvest, the bone marrow was processed through Ficoll density gradient separation as previously described to isolate the bone marrow mononuclear cells (BM-MNCs) [27] .
In brief, the marrow is filtered through 100-μm cell strainers to remove clot and bone spicules. A 1:1 dilution with PBS is performed and the bone marrow is layered onto Ficoll 1077 (Sigma-Aldrich, St. Louis, MO, USA). After centrifugation, the plasma and mononuclear cell layers are isolated. The mononuclear cell layer undergoes two washes with PBS to yield a cell pellet that is diluted in 20 mL of PBS for the purposes of seeding the graft. The cells are vacuum-seeded onto the graft (Fig. 1c) and TEVG is incubated in plasma for 1 h (n = 2) or 24 h (n = 2) at 37°C, 5% CO 2 until implantation.
Implantation
The grafts are implanted in the thoracic caudal vena cava (CaVC) as previously described. For the purposes of this paper, caudal vena cava refers to the venous structure that returns blood flow to the heart from the abdominal structures and is equivalent to the inferior vena cava in humans. The TEVG is designed for use as a vascular conduit to connect the inferior vena cava to the pulmonary artery in patients with single-ventricle anomalies undergoing Fontan surgery. As the spontaneous occurrence of single-ventricle defects is rare and surgical creation of this anomaly results in high mortality, this system is chosen to replicate the low-pressure, high-flow physiology encountered within these patients. While there are some clear differences, including a lower pressure (0-10 mmHg in the sheep versus 20-30 mmHg in Fontan circulation), the anatomic position distal to the liver allows observation of similar complications from stenosis as those that would be seen clinically, such as chronic passive congestion, cirrhosis, and ascites. Additionally, the graft is exposed to similar flow, resulting in a relevant and comparable model to patients who undergo a Fontan procedure.
Animals (n = 8) were placed in a lateral recumbent position on the operating table. Anesthesia was maintained with isoflurane. The right thorax was prepped and draped in the normal sterile fashion. An incision was made in the seventh intercostal space and the thoracic CaVC was isolated between the diaphragm and the right atrium. After proximal and distal control was obtained, the vessel was divided. No native vessel was removed. An unseeded (n = 4) or seeded (n = 4) tissueengineered vascular graft was sewn in place using a running absorbable monofilament suture and covered with thrombin glue. The chest wall, overlying muscle, and skin layers were re-approximated with absorbable braided suture.
Interventional Imaging
Imaging was performed at 1, 3, and 6 months. Additional monitoring was performed as determined by the study team based on the animal's clinical condition and results of previous imaging.
Angiography
After sedation and intubation, the animals were placed in a left lateral recumbent position and the right cervical region was prepped in a sterile fashion. The right internal jugular vein was cannulated and a 9-French sheath (Terumo, Somerset, NJ) inserted. A wire and catheter were passed through the right atrium, into the caudal vena cava (CaVC), and across the graft. A 6-French Multi-track catheter (B. Braun, Bethlehem, PA) was then used to obtain an angiogram through instillation of ioversol 68% (Mallinckrodt Pharmaceuticals, Raleigh, NC). Diameters of vessels were measured at seven points: abdominal CaVC, low CaVC, proximal anastomosis, midgraft, distal anastomosis, high CaVC, and the area of most severe stenosis (Fig. 1d) .
Intravascular Ultrasound (IVUS)
A 0.035 digital IVUS catheter (Volcano, San Diego, CA) was advanced past the graft. This was used to obtain images at the same seven points measured during angiography. Longitudinal images were obtained without the use of a sled. This approach generates longitudinal images that are not representative of the graft length. These were then analyzed using proprietary imaging software to obtain a cross-sectional luminal area (Fig. 1e) .
Balloon Angioplasty
Balloon angioplasty was performed based on clinical discretion.
Animal Euthanasia
At the study end point or as clinically indicated, animals were deeply sedated with ketamine (20 mg/kg) and diazepam (0.02-0.08 mg/kg), followed by induction of secondary pneumothorax. A complete autopsy was performed at time of TEVG explantation.
Tissue Processing, Histology, and Immunofluorescent Staining TEVG explants were fixed in 10% neutral buffered formalin at 4°C, trimmed, dehydrated, and embedded in paraffin. Tissue samples, which were 4-5-μm-thick serial sections, were prepared and stained with hematoxylin and eosin (H&E) and Masson's Trichrome. Immunofluorescent (IF) stains were performed to identify α-smooth muscle actin (α-SMA) and von Willebrand factor (vWF) positive cells in the TEVG neotissue. Briefly, sections were deparaffinized, rehydrated, and antigens retrieved via the citrate buffer method (pH 6.0, 90°C). Sections were blocked for nonspecific antibody binding (3% normal goat serum) and incubated overnight at 4°C with an antibody cocktail of mouse anti-human α-SMA (1:100; Dako) and rabbit anti-human vWF (1:200; Dako) which both cross-react with the ovine antigens. Antibody binding was detected by subsequent incubation with goat-anti-mouse Alexa-Fluor® 647 (1:300; Life Technologies) and goat-anti-rabbit Alexa-Fluor® 488 (1:300; Life Technologies) followed by nuclear counterstaining with DAPI (Life Technologies). Photomicrographs were acquired with a Zeiss Axio Observer Z.1 microscope with Zeiss Axiocam 503 (dark field) and 105 (bright field) digital cameras. Exposure time was informed by the appropriate negative controls.
Statistical Analysis
Lumen diameter measurements from angiography were compared to lumen diameters calculated from IVUS luminal area measurements Diameter ¼ 2
ffiffiffiffiffiffi ffi
Area π q . Similarly, lumen area measurements from IVUS were compared to lumen areas calculated from angiographic luminal diameter measurements
The degree of TEVG stenosis (%) at each time point was calculated by dividing the change in angiographic lumen diameter or IVUS lumen area by the corresponding implantation measurement. IVUS and angiographic data were considered paired if they were derived from the same level of the TEVG or native CaVC at the same time point. Statistical analyses were performed using GraphPad Prism 7 (GraphPad Software, Inc., CA). Type I error was controlled at α = 0.05 and two-sided p values <0.05 were considered statistically significant. Associations among variables were evaluated using Pearson correlation coefficients, and significantly correlated variables were further subjected to Bland-Altman agreement analysis.
Results

Animal Outcomes
A total of eight animals underwent implantation (four unseeded, four seeded). Of these animals, 75% (n = 6) did not reach the end point of 6 months. In vivo complications included stenosis (n = 4), graft dilation (n = 1), thrombosis (n = 4), wound infection (n = 1), pericardial tamponade (n = 1), pneumonia (n = 1), and renal insufficiency (n = 3).
IVUS Characterization of Neovessel Formation
IVUS Characterization Over Time
Intravascular ultrasound identified the presence (Fig. 2a) or absence of luminal fibrin and platelet deposition at the time of implantation. There was a paucity of tissue formation within the intima, media, or adventitia of the graft. At approximately 1 month post-implantation, the neointima had developed and was lined by an endothelium and neomedia inside the lumen of the graft (represented by a hyperechoic laminar layer) (Fig. 2b) . The endothelial lining became more clearly defined as the tissue organized and remodeled between 3 and 6 months (Fig. 2c) . At 6 months, as the graft degraded, the hyperechoic polymeric layers became less clearly defined on IVUS (Fig. 2d) .
IVUS Findings over the Length of the Graft
IVUS findings in the low CaVC illustrated a thin-walled vessel consistent with histologic findings (Fig. 3) . At the proximal and distal anastomosis (Fig. 3b, d) , thickening of the neointimal and neomedial layers was present in both the IVUS and histologic images. The hyperechoic inner layer seen on IVUS correlated with the neointima on both Masson's Trichrome and IF analyses. The neomedia was hypoechoic on IVUS and characterized by a higher density extracellular matrix (including collagen) as seen on trichrome and vascular smooth muscle cells as seen with IF. The midgraft section (Fig. 3c) was noted to have a thinner layer in this area, which correlated to a thinner neointima and neomedia.
Comparison of Angiography and IVUS by Quantification of Lumen Geometry
Lumen diameter approximations from IVUS imaging were significantly correlated with angiographic measurements (Fig. 4a , Pearson r = 0.8669, p < 0.0001). Conversely, calculated luminal area derived from angiographic imaging were not significantly correlated with IVUS area measurement (Fig. 4b , Pearson r = 0.2886, p = 0.0832). When the degree of stenosis at each time point was calculated based on the corresponding measurements from the implant, a significant correlation between IVUS and angiography was discovered (Fig. 4c , Pearson r = 0.6952, p < 0.0001). Significant correlations prompted characterization of the agreement between IVUS and angiography by Bland-Altman analysis to investigate whether these modalities could be used interchangeably for the determination of lumen diameter and degree of stenosis. With regards to approximation of lumen diameter, the mean difference between IVUS and angiography was 0.739 ± 2.055 mm (Fig. 4d, 95% confidence interval 0.077 to 1.401 mm, 95% limits of agreement −3.288 to 4.767 mm). While quantification of stenosis was significantly correlated between the two modalities, the agreement between IVUS and angiography was not robust (Fig. 4e , bias 1.863 ± 36.84%, 95% confidence interval −5.749 to 9.475, 95% limits of agreement −70.35 to 74.08%).
Characterization of Anomalies
Strengths of IVUS
Characteristics of the graft that were clearly identifiable on angiography included anastomotic narrowing, stenosis, dilation, and compression (Fig. 5 ). These problems are easily identified with IVUS and correlated with angiographic imaging. While IVUS demonstrated these changes, it may be less likely to identify some of the sequelae of the pathology, such as collateralization with severe stenosis (Fig. 5b) . However, angiography may not be able to readily identify narrowing or other pathology that occurs due to its single axis view. An example of this pathology is seen in Fig. 5d , which shows the narrowing of the vessel in the anterior/posterior direction as it traverses the diaphragm. This anomaly may be less readily identified with angiography when only one view is acquired. In addition, IVUS can specifically identify and characterize intimal depositions, such as fibrin and platelet deposition (Fig. 6a) . In this comparison, the relationship between the graft and fibrin and platelet deposition was more specifically characterized by IVUS than angiography where only the luminal narrowing could be identified. Following balloon dilation, IVUS was also able to identify therapeutic tears (Fig. 6b) . While this change was apparent on angiography, its spatial relationship to the graft, neotissue, and surrounding tissues could not be evaluated. A tear through the neotissue and graft, as well as containment within the surrounding tissue was clearly identifiable both on IVUS and histology (Fig. 6b) .
Weaknesses of IVUS
Histopathologic assessment offers a greater subgross resolution of neotissue formation, extracellular matrix composition, and polymeric graft degradation in comparison to IVUS. Important findings specific to histology, not identified by IVUS, include mineralization or microcalcification. Additionally, with IVUS, as the graft matured and the scaffold degraded, the tissue layers were less readily discerned. This finding is highlighted at the 180-day time point shown in Fig. 2d .
Discussion
Currently, patients who receive TEVGs are closely monitored clinically and with serial echocardiogram. If indicated, these children may also undergo MRI or angiography. While these studies can identify dilation, stenosis, or changes in intravascular flow, they are less informative regarding the changes that are occurring within the wall of the neovessel. Data interpretation generated by these studies is limited and correlation with histologic findings in the clinical setting is also limited. Our previous work with murine models has characterized the natural time course of neotissue formation that occur following TEVG implantation, as it progresses to a neovessel that has similar characteristics to that of native vein [28, 29] . Time-course studies over 6 months have characterized both in vivo changes by ultrasound as well as ex vivo with histology and biomechanical testing. As with echocardiography in the clinic, this technique is useful to determine patency versus stenosis and provides some limited information regarding flow. However, histology continues to provide the majority of data for analysis of changes within the vessel wall in preclinical settings. While histologic analysis has been the gold standard in both our murine and ovine models, IVUS offers the potential to evaluate the progression of changes within our ovine model over time in vivo within the same animals, obviating the need for serial explantation. The results described in this study highlight the capacity of IVUS to follow changes that occur within the wall of the graft over time, including acute and chronic responses to angioplasty. In comparison to histology, the progressive changes in the endothelium, underlying neotissue, and graft degradation clearly correlate with IVUS findings. In the current study, IVUS is able to demonstrate all relevant graft components at early time points, but by 180 days these findings are no longer present. These results suggest that IVUS will be able to monitor not only neotissue development but the degradation of the graft over time.
The IVUS analysis over the length of the graft also provides support for the use of the modality for graft analysis. Our previous work has shown that the cells seeded onto the graft modulate the innate humoral and cell-mediated inflammatory response, stimulating ingrowth of cells from the adjacent Immunofluorescent images of TEVG immunolabeled for vWF (green) and α-SMA (red). Neovessel layers are outlined as follows: dotted linelumen; dashed line-graft polymer; solid line-adventitia; asterisksuture; L-lumen. While an endothelial lining is present along the length of the graft, differential vascular smooth muscle cell labeling along the length of the graft can be appreciated native vessel [28] . IVUS successfully captures the differences in thickness of the neovessel wall over the length of the graft, and these changes can be correlated with histologic images. These results suggest that IVUS can be used to follow the formation of an endothelial lining, the development of a neomedia that is comprised of vascular smooth muscle cells, and the eventual maturation of the neotissue. As IVUS correlates with angiographic and histologic findings, further evaluation of this technique within the ovine model may allow characterization of changes within these tissue planes that could be used to identify grafts that will progress to stenosis or, alternatively, stenotic segments that will resolve without need for angiographic intervention. One limitation may be the availability of this modality and clinicians that are experienced with IVUS for evaluation of this specific indication.
With regards to the capacity of IVUS to quantify vessel geometry, there was a significant correlation between lumen diameters approximated from IVUS measurements and angiographic measures of lumen diameters at the same level of the graft and there existed a clear agreement between these two modalities. This indicates that IVUS is able to determine the measurements obtained by both the one-dimensional angiography while also providing a two-dimensional area, which one-plane angiography was unable to approximate. We propose that IVUS is the best modality to assess the asymmetrical lumens of the ovine vena cava at physiological pressure and is therefore better suited to evaluate TEVG growth and remodeling in this model. Further, traditional angiography cannot be used with confidence to approximate a luminal area when compared to IVUS. Graft lumen area may better approximate IVUS measurements when 3D angiography is employed, but this requires a significant increase in both contrast and radiation. Taken along with the advantages of IVUS evaluation of vascular neotissue described herein, the lack of strong agreement with regards to percent stenosis determinations between IVUS and angiography further supports the use of IVUS for longitudinal surveillance of TEVGs in vivo. Clinically, the ability of IVUS to obtain an accurate luminal area and diameter at physiologic conditions should allow a significant reduction of contrast and radiation exposure, an especially important concern in the pediatric population undergoing multiple cardiac catheterizations. Further 1-3 ) following balloon dilation. Fibrin and platelet deposition can be visualized with both imaging formats and by histology (hematoxylin and eosin, 5×). The shadow of the contained leak can be seen on angiography, but the relationship to the neotissue and graft material is better appreciated with IVUS and histology. The line on angiography denotes correlative position of IVUS and histologic images research in our animal model and in the clinic will be needed to further assess this benefit.
The ability of IVUS to identify abnormalities has previously been documented including its ability to demonstrate vessel interfaces with stent use [6, 26] and to clearly identify false lumens [11] . These strengths are similar to those we have characterized above when evaluating TEVGs. Examples include the ability to monitor the degradation of the graft and the ability to identify therapeutic tears and the resultant contained fluid collections in the surrounding tissue. While IVUS has many strengths, there are several weaknesses when compared to histologic techniques. While previous studies have been able to view calcific plaques within the vessel wall [18] , two of the specimens demonstrated microcalcifications that were not identified on either angiography or IVUS (data not shown). Additionally, once the graft degrades and tissue maturation has occurred at 6 months, tissue planes are not as easily identified on IVUS. However, the findings at this point are similar to those in the native vena cava and are confirmed by histologic similarity between native and tissue-engineered vena cava at late time points. While commonly utilized imaging techniques such as angiography, CT, MRI, or echocardiogram are unable to visualize these tissue planes, optical coherence tomography (OCT) has been used experimentally to evaluate coronary plaques. This technique uses infrared light and has a high resolution of 10-15 μm, but has a limited penetration into tissue (1.5 mm) [30] . While this technique might provide a more detailed picture of tissue closest to the luminal surface, the depth of penetration would limit its application for imaging of the TEVG.
Data from the current study demonstrates that serial IVUS can be used safely in vivo in animals that have undergone implantation of a TEVG in the thoracic vena cava. The use of this technology complements angiography and provides a more detailed examination of the neovessel wall, including neotissue development. With longitudinal studies involving the same animals, a detailed analysis of neotissue formation on the graft with associated luminal narrowing as well as the remodeling of this tissue can be more closely monitored. Additionally, IVUS is able to identify common abnormalities from graft implantation and their spatial relationship to the graft material. Extending this technology using backscatter analysis or virtual histology would allow more detailed examination of the TEVG in vivo, which may inform the use of interventions such as angioplasty or stenting in the clinic. Our data suggests that the measurements obtained by IVUS agree with angiographic measurements and provide superior quantification of neovessel geometry, which could benefit patients in the clinical setting by decreasing contrast and radiation exposure. Finally, IVUS offers the potential to follow both animal models and patients with TEVGs longitudinally, allowing direct correlative data from one subject over time.
Conclusion
IVUS identification of neotissue and graft lumen morphometry correlates closely with both angiography and histology, and can provide further analysis of the maturation of tissueengineered vascular grafts.
